Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 102

Results For "ISA"

1071 News Found

Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation
Healthcare | August 16, 2021

Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation

National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India, set up to establish and operate accreditation programmes for healthcare organisations


India restricts export of Rapid Antigen Test Kits used to detect Covid 19
Policy | August 16, 2021

India restricts export of Rapid Antigen Test Kits used to detect Covid 19

The notification implies that any export of Rapid Antigen Kit will require a licence or permission from DGFT


India observes its first `Prediabetes Day' on August 14
Healthcare | August 14, 2021

India observes its first `Prediabetes Day' on August 14

Fitterfly has launched an online Prediabetes risk test which is an evidence-based, clinically validated tool for assessing an individual's risk of Prediabetes


Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores
News | August 13, 2021

Aurobindo Pharma buys Cronus Pharma Specialities for Rs 420 crores

The acquisition will provide it with a foothold in the US $ 48 billion global animal health market


Sun Pharma Speciality business looks encouraging: HDFC Securities
News | August 13, 2021

Sun Pharma Speciality business looks encouraging: HDFC Securities

Winlevi, the recently added anti-acne product with a new mechanism of action and broad-based use (vs Absorica), will further boost the derma portfolio and Speciality business growth


JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22
News | August 13, 2021

JB Chemicals & Pharmaceuticals PAT at Rs. 118.9 cr for Q1 FY22

Domestic formulations business records 39 % growth while the international business revenue was largely flat as compared to Q1 FY21


Indian pharma market grew by 13.7% in July 2021: Ind-Ra
News | August 12, 2021

Indian pharma market grew by 13.7% in July 2021: Ind-Ra

Demand normalisation post the second wave contributed to the steady growth


Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness
Drug Approval | August 12, 2021

Human studies begin on AI discovered COVID-19 treatment with up to 97% effectiveness

A treatment to prevent extreme symptoms and cut hospitalisation


Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
Digitisation | August 11, 2021

Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx

OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.


GW Pharmaceuticals receives approval for Epidyolex to treat seizures
Drug Approval | August 11, 2021

GW Pharmaceuticals receives approval for Epidyolex to treat seizures

TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines